Explore the world of biotechnology with CharaBio’s exclusive “Listen To The Biotech Expert” online series. Engage in captivating discussions with influential figures shaping the biotech landscape. These conversations aim to inspire future scientists, medical professionals, and entrepreneurs to explore the exciting option of establishing their own biotech companies, drawing insights from those who have innovated and made a lasting impact.
Episode 1 with Dr. Francesco Marincola (CSO at Sonata Therapeutics, a Flagship Pioneering Company)
CharaBio is excited to present the inaugural episode of our “Listen to the Biotech Expert” series, featuring a virtual fireside chat with Dr. Francesco Marincola, Chief Scientific Officer (CSO) at Sonata Therapeutics and former CSO at Kite Pharma. As we prepare for the upcoming launch of the First4Founders community in January 2024, this event promises a deep exploration into oncology, immunology, and cell therapy.
In this fireside chat, Dr. Marincola, with over 30 years of expertise in research and development, will share unique insights into the nuances of R&D for cell therapy products compared to other modalities. Join us as we delve into topics such as unlocking the potential of adoptive cell therapy, the latest advances in oncology and immunology, transitioning from cutting-edge research projects to viable biotechs, and the qualities that make a great Biotech CSO.
This event is a must-watch for scientists, medical doctors, biotech entrepreneurs, and C-suite executives seeking valuable knowledge from one of the industry’s foremost experts. As part of the First4Founders initiative, CharaBio is dedicated to fostering the next generation of biotech leaders. Students and recent graduates can request a guest pass by emailing contact@charabio.com.
You can now watch the Episode on our YouTube Channel CharaBio Talks
Dr. Francesco Marincola’s BIO
With a distinguished career that spans roles at Kite Pharma, Refuge Biotechnologies, AbbVie, Sidra Medical and Research Centre, and leadership positions at the National Institutes of Health (NIH) and National Cancer Institute (NCI), Dr. Marincola brings a wealth of experience to the discussion. As the CSO at Sonata Therapeutics, a Flagship Pioneering company, he continues to lead innovative research, holding an M.D. from the University of Milan and completing his residency at Stanford University. Dr. Marincola’s extensive portfolio includes over 600 peer-reviewed publications, and he currently serves as the Editor-in-Chief for multiple prestigious peer-reviewed publications.
To kick-start your entrepreneurial journey in biotech, we have prepared a “Template for Pharma and Biotech Startup Pitch Deck“, reviewed by 21 leading VCs actively investing in biotech companies. But that’s just the beginning!
Stay tuned for more valuable content, resources, and expert insights to support your journey. Sign up for updates and be the first to access this community.
Whether you’re a brilliant scientist, a medical doctor, or an experienced industry professional, we speak your language. First4Founders welcomes individuals from diverse backgrounds who share a passion for biotech, pharma, and healthcare innovation.